HDAC inhibitors (Sanford Burnham Prebys Medical Discovery Institute/Fondazione Santa Lucia IRCCS/Università Cattolica del Sacro Cuore)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHDAC inhibitors (Sanford Burnham Prebys Medical Discovery Institute/Fondazione Santa Lucia IRCCS/Università Cattolica del Sacro Cuore)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesSanford Burnham Prebys Medical Discovery Institute
China Registration ClassN/A

Develop Information

Active CompaniesUniversità Cattolica del Sacro Cuore-IRCCSFondazione Santa Lucia IrccsSanford Burnham Prebys Medical Discovery Institute
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A